Entering here for a possible inv h&s continuation targeting 240. (1.618 fib level).
Stop loss @120. Should be a good spot to take profits and leave half running.
News - Better than expected Q4 EPS and sales results, the company expects to authorize a shares repurchase program up to 1.5B over the next two years.
Levels -$195 is the next major resistance level.
$138 is the next major support level.
The stock is gapping up to $183 (pre-market).
The idea is to go long at the open when it will try to test the $183 support...
BNTX has broken out nicely upon earnings
it also aligns nicely with the pattern price is portraying which is an ascending scallop, commonly considered a bullish pattern
Underrated company in my opinion with perspective pipeline. Now it has 2/3 ichi confirmation + bullish rsi + incoming earnings, shall be more clear tomorrow
We just finished Elliot wave 1-5 and ABC pattern, already bounced off of a strong demand zone and 71.8% fib zone we can enter right now but our R/R ratio is 1.7 since we missed first bounce, what we are looking for is a retrace to our entry point ant 71.8% fib zone and enter there. Also market made a gap at 182 zone which has to be filled. Also a gap at 325 zone,...
BioNTech Q4 December 21' earnings are on 3/30 pre-market 6:45am. BioNTech Se ADR (BNTX) reported Q3 September 2021 earnings of $14.56 per share on revenue of $7.2 billion. The consensus earnings estimate was $11.79 per share on revenue of $5.8 billion. Revenue grew 9,003.0% on a year-over-year basis. I'm long now because a P/E = 3.7 for a leading MRNA...
Enter after breaking the trendline.
Even if the end of the epidemic has a big impact on the price, it is still possible enter a long position and be a winner!
$bntx has NO volume support until green box 24% lower... #bntx
——————————————————————————————
Top 10 trading tips:
1. DO NOT FOMO into a trade. Let it come to you. Don’t force it.
2. Find a strategy that works for you and be consistent. Operate like a machine and less like the wind.
3. Let your winners run and cut your losers short.
4. You will not win every...
BNTX looks to be in a descending wedge and coming to its peak.
I have highlighted the red line horizontal resistance levels to watch in the event of a breakout.
Orange lines are the nPOC levels of interest.
Green line should be major support area at 120.
Descending wedge PT would be top of wedge.
bntx is approaching extreme support here, a couple outcomes can happen.
we either bounce here and test top trendline before pullback, or we test the bottom of extreme support range first.
Both are profitable outcomes if you play it right, like and follow for more 💘
For 1/3, intraday trading ideas for options trading; not financial advice, 2 plans for red or green market day.
Break over 264 (entry, long), it can see 275-282 (exit)
Break below 251 (entry, short), it can see 233-240 (exit)
#options #daytrading
Option Trading 101:
Risk what you can lose (0.5%-5%)
Watch buyers and sellers (their interactions & sentiment,...
Biontech seems to be at a critical point and repeating a couple of previous runs.
Pattern will be more defined by next week whether that run would happen or not.
Hello Traders,
welcome to this free and educational analysis.
I am going to explain where I think this asset is going to go over the next few days and weeks and where I would look for trading opportunities.
If you have any questions or suggestions which asset I should analyse tomorrow, please leave a comment below.
I will personally reply to every single...
BioNTech SE engages in the development of novel medicines at the intersection of immunology and synthetic biology. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Ozlem Tureci and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.
NASDAQ
